Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2009

View Archived Issues

SASP PT1.2 reduces antibiotic resistance and retains activity when co-applied with other antibiotics

Novel serine/threonine kinase inhibitors discovered by Schering-Plough for cancer treatment

Wyeth presents novel Raf kinase B inhibitors for cancer treatment

Sanofi-aventis presents novel GHS receptor antagonists for the treatment of obesity

GlaxoSmithKline describes novel monoamine reuptake inhibitors as antidepressants

CP-751871 combined with chemotherapy shows promise in phase II trial in NSCLC patients

ITMN-520 prevents airway hyper-responsiveness in murine model of allergen-induced airway dysfunction

EpiCept partners with IDIS for compassionate use Ceplene program

Swissmedic grants approval for clinical study of Neovacs' TNFalpha-kinoid

Pfizer launches Toviaz and YourWay support plan for overactive bladder patients in the U.S.

FDA advisory committee to review ISTA's NDA for Bepreve in June 2009

HHS awards contract to MedImmune to make nasal spray vaccine for H1N1

Celldex enters into definitive agreement to acquire CuraGen

AstraZeneca and Merck & Co. collaborate on novel combination anticancer regimen

Atlantic Healthcare receives EMEA orphan drug status for alicaforsen in pouchitis

NIM-811 may benefit the liver after massive hepatectomy

Cleveland BioLabs concludes initial phase I safety study for CBLB-502

Lilly resubmits Cymbalta supplemental NDA to FDA for chronic pain

Biken launches dry cell-cultured Japanese encephalitis vaccine Jebik V

Phase I results encourage continued study of TRU-016 in chronic lymphocytic leukemia

Clinical study points to oncolytic activity of PF-02341066 in ALK-dependent tumors

TorreyPines Therapeutics' Board of Directors approves of plan of liquidation

AJM-300 benefits some Crohn's disease patients in double-blind trial

NCI initiates phase II clinical trial of Rigel's oral Syk inhibitor R-788 in multiple cancers

Antiinfective Drugs Advisory Committee completes review of ALS' Restanza for CAP

Nuvigil launched for sleepiness associated with several sleeping disorders

Genzyme receives positive CHMP opinion for Mozobil in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...